Biodesix Shares Outstanding History (BDSX)
Biodesix reported 8.3M shares outstanding at the end of fiscal 2025.
View full Biodesix company overviewBiodesix annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 8.3M | 978,475 | +13.45% |
| 2024 | 2024-12-31 | 7.3M | 2.5M | +51.18% |
| 2023 | 2023-12-31 | 4.8M | 931,076.25 | +23.99% |
| 2022 | 2022-12-31 | 3.9M | 2.3M | +152.08% |
| 2021 | 2021-12-31 | 1.5M | 211,407.25 | +15.92% |
| 2020 | 2020-12-31 | 1.3M | 1.3M | +10319.63% |
| 2019 | 2019-12-31 | 12,745.9 | — | — |
Biodesix quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 10.5M | 3.2M | +43.94% |
| Q1 2026 | 2026-03-31 | 10.1M | 2.8M | +38.04% |
| Q4 2025 | 2025-12-31 | 8.3M | 978,474.55 | +13.45% |
| Q3 2025 | 2025-09-30 | 8.0M | 681,243.95 | +9.37% |
| Q2 2025 | 2025-06-30 | 7.3M | 71,724 | +0.99% |
| Q1 2025 | 2025-03-31 | 7.3M | 2.5M | +50.72% |
| Q4 2024 | 2024-12-31 | 7.3M | 2.5M | +51.18% |
| Q3 2024 | 2024-09-30 | 7.3M | 2.9M | +64.71% |
| Q2 2024 | 2024-06-30 | 7.3M | 3.3M | +84.64% |
| Q1 2024 | 2024-03-31 | 4.9M | 959,003.6 | +24.60% |
| Q4 2023 | 2023-12-31 | 4.8M | 931,076.25 | +23.99% |
| Q3 2023 | 2023-09-30 | 4.4M | 2.4M | +114.43% |
| Q2 2023 | 2023-06-30 | 3.9M | 1.9M | +96.63% |
| Q1 2023 | 2023-03-31 | 3.9M | 2.3M | +144.53% |
| Q4 2022 | 2022-12-31 | 3.9M | 2.3M | +152.08% |
| Q3 2022 | 2022-09-30 | 2.1M | 708,273.1 | +52.43% |
| Q2 2022 | 2022-06-30 | 2.0M | 651,498.25 | +48.35% |
| Q1 2022 | 2022-03-31 | 1.6M | 255,194.3 | +19.05% |
| Q4 2021 | 2021-12-31 | 1.5M | 211,407.25 | +15.92% |
| Q3 2021 | 2021-09-30 | 1.4M | 1.3M | +55300.49% |
| Q2 2021 | 2021-06-30 | 1.3M | 1.3M | +10471.59% |
| Q1 2021 | 2021-03-31 | 1.3M | — | — |
| Q4 2020 | 2020-12-31 | 1.3M | — | — |
| Q3 2020 | 2020-09-30 | 2,438.613 | — | — |
| Q4 2019 | 2019-12-31 | 12,745.9 | — | — |
Biodesix shares outstanding trends
Over the last five reported fiscal years, Biodesix's shares outstanding moved from 1.3M to 8.3M, a change of 6.9M. The latest reported quarter, Q2 2026, shows 10.5M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biodesix filings at SEC.gov ↗